Mehboob Makhani, MD
Psychiatry · Northridge, CANPI 1386610988
Payments from drug & device makers
Across 16 payments — averaging $16.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$63
- Lundbeck LLC$46
- Vanda Pharmaceuticals Inc.$39
- Alkermes, Inc.$37
- Neurocrine Biosciences, Inc.$36
- E.r. Squibb & Sons, L.L.C.$26
- plus $17 from 1 others
What the payments were for
- Food & beverage$264100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $63 |
| Lundbeck LLC | 3 | $46 |
| Vanda Pharmaceuticals Inc. | 1 | $39 |
| Alkermes, Inc. | 2 | $37 |
| Neurocrine Biosciences, Inc. | 1 | $36 |
| E.r. Squibb & Sons, L.L.C. | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
How this compares
$264 in reported general payments places this provider in the 55th percentile of 4,954 psychiatry providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 12 | $36,018 |
| Divalproex Sodium | 310 | $10,826 |
| Aripiprazole | 65 | $8,632 |
| Quetiapine Fumarate | 370 | $5,849 |
| Haloperidol | 69 | $4,393 |
| Olanzapine | 210 | $3,855 |
| Risperidone | 217 | $3,522 |
| Divalproex Sodium ErDivalproex Sodium | 42 | $2,580 |
| Clozapine | 24 | $2,364 |
| Chlorpromazine Hcl | 17 | $2,021 |
| Benztropine Mesylate | 119 | $1,955 |
| Carbamazepine | 28 | $1,614 |
| Trazodone Hcl | 145 | $1,545 |
| Buspirone Hcl | 99 | $1,509 |
| Fluvoxamine Maleate | 30 | $1,416 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Northridge
- Elly LeeIrvine$49.8M
- Daniel ChuehOrange$17.9M
- Eric ChavezSan Diego$15.5M
- Lara ShirikjianTorrance$12.6M
- John DuffySanta Ana$12M
- Marina BusselPlaya Vista$12M
- Sherry SoefjeOceanside$11.9M
- Steven MacinaHuntington Beach$11.1M
- Wakelin McNeelRosemead$11M
- Donald AndersonBanning$10.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.